fluoxetine


SMILES CNCCC(c1ccccc1)Oc1ccc(cc1)C(F)(F)F
InChIKey RTHCYVBBDHJXIQ-UHFFFAOYSA-N

Chemical properties

Hydrogen bond acceptors 2
Hydrogen bond donors 1
Rotatable bonds 6
Molecular weight (Da) 309.1

Drug properties

Molecular type Small molecule
Physiological/Surrogate Surrogate
Approved drug Yes

Bioactivities

Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
5-HT2B 5HT2B Human 5-Hydroxytryptamine A pKi 5.3 5.3 5.3 Guide to Pharmacology
5-HT6 5HT6R Rat 5-Hydroxytryptamine A pKi 5.8 5.8 5.8 Guide to Pharmacology
5-HT2A 5HT2A Rat 5-Hydroxytryptamine A pKi 6.5 6.5 6.5 Guide to Pharmacology
5-HT2C 5HT2C Rat 5-Hydroxytryptamine A pKi 7.3 7.3 7.3 Guide to Pharmacology
α2B ADA2B Human Adrenoceptors A pKi 6.16 6.16 6.16 ChEMBL
M5 ACM5 Human Acetylcholine (muscarinic) A pKi 6.01 6.01 6.01 ChEMBL
M3 ACM3 Human Acetylcholine (muscarinic) A pKi 6.12 6.12 6.12 ChEMBL
5-HT6 5HT6R Human 5-Hydroxytryptamine A pKi 6.11 6.11 6.11 ChEMBL
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pKi 7.14 7.17 7.21 ChEMBL
M1 ACM1 Human Acetylcholine (muscarinic) A pKi 6.11 6.11 6.11 ChEMBL
5-HT2A 5HT2A Human 5-Hydroxytryptamine A pKi 7.26 7.26 7.26 ChEMBL
5-HT2A 5HT2A Human 5-Hydroxytryptamine A pKi 8.18 8.18 8.18 Drug Central
5-HT2B 5HT2B Human 5-Hydroxytryptamine A pKi 8.28 8.28 8.28 Drug Central
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pKi 8.19 8.19 8.19 Drug Central
5-HT6 5HT6R Human 5-Hydroxytryptamine A pKi 8.21 8.21 8.21 Drug Central
M1 ACM1 Human Acetylcholine (muscarinic) A pKi 8.22 8.22 8.22 Drug Central
M2 ACM2 Human Acetylcholine (muscarinic) A pKi 8.25 8.25 8.25 Drug Central
M3 ACM3 Human Acetylcholine (muscarinic) A pKi 8.22 8.22 8.22 Drug Central
M4 ACM4 Human Acetylcholine (muscarinic) A pKi 8.26 8.26 8.26 Drug Central
M5 ACM5 Human Acetylcholine (muscarinic) A pKi 8.25 8.25 8.25 Drug Central
α1A ADA1A Human Adrenoceptors A pKi 8.24 8.24 8.24 Drug Central
α2A ADA2A Human Adrenoceptors A pKi 8.09 8.09 8.09 Drug Central
α2B ADA2B Human Adrenoceptors A pKi 8.21 8.21 8.21 Drug Central
β1 ADRB1 Human Adrenoceptors A pKi 8.27 8.27 8.27 Drug Central
D3 DRD3 Human Dopamine A pKi 8.24 8.24 8.24 Drug Central
H1 HRH1 Human Histamine A pKi 8.22 8.22 8.22 Drug Central
5-HT6 5HT6R Rat 5-Hydroxytryptamine A pKi 8.24 8.24 8.24 Drug Central
5-HT2A 5HT2A Rat 5-Hydroxytryptamine A pKi 8.19 8.19 8.19 Drug Central
α2A ADA2A Human Adrenoceptors A pKi 8.2 8.2 8.2 ChEMBL
H3 HRH3 Human Histamine A pKi 5.14 5.14 5.14 ChEMBL
H3 HRH3 Human Histamine A pKi 8.29 8.29 8.29 Drug Central
5-HT2C 5HT2C Rat 5-Hydroxytryptamine A pKi 6.96 6.96 6.96 ChEMBL
5-HT2C 5HT2C Rat 5-Hydroxytryptamine A pKi 8.16 8.16 8.16 Drug Central
Receptor Activity Source
GTP Uniprot Species Family Class Type Min Avg Max Database
GPR183 GP183 Human Orphan A pIC50 5.18 5.18 5.18 ChEMBL
α2B ADA2B Human Adrenoceptors A pIC50 5.82 5.82 5.82 ChEMBL
M5 ACM5 Human Acetylcholine (muscarinic) A pIC50 5.87 5.87 5.87 ChEMBL
M3 ACM3 Human Acetylcholine (muscarinic) A pIC50 5.44 5.44 5.44 ChEMBL
5-HT6 5HT6R Human 5-Hydroxytryptamine A pIC50 5.78 5.78 5.78 ChEMBL
5-HT2C 5HT2C Human 5-Hydroxytryptamine A pIC50 6.8 6.86 6.92 ChEMBL
M1 ACM1 Human Acetylcholine (muscarinic) A pIC50 5.49 5.49 5.49 ChEMBL
apelin APJ Human Apelin A pIC50 5.47 5.47 5.47 ChEMBL
5-HT2A 5HT2A Human 5-Hydroxytryptamine A pIC50 6.15 6.43 6.71 ChEMBL
CX3CR1 CX3C1 Human Chemokine A pIC50 5.52 5.52 5.52 ChEMBL
GPR35 GPR35 Human Orphan A pIC50 5.08 5.08 5.08 ChEMBL